Treatment Information

Back

Lung Cancer treatment details. Chemotherapy.

Oncology Institute of Bari, Bari, Italy.

Survival: monthsCountry:Italy
Toxiciy Grade:4City/State/Province:Bari
Treatments:ChemotherapyHospital:Oncology Institute of Bari
Drugs:Journal:Link
Date:Oct 2002

Description:

Patients: This Phase II study involved 47 patients with advanced (stage IIIB or IV) non-small-cell lung cancer.

Treatment: Treatment consisted of two drugs – gemcitabine (gemzar) and docetaxel (taxotere).

Toxicity: Toxicity included grade 3-4 neutropenia, grade 1-3 anemia, grade 1-2 and 4 thrombocytopenia, grade 3-4 alopecia, grade 3-4 asthenia, and grade 3 nausea/vomiting.

Results: Median survival was 10.5 months (11 months for the stage IIIB patients and 10 months for the stage IV patients).

Correspondence: D. Galetta, MD




Back